Good News! 3 Cases of Improvement in Alzheimer's and Dementia
Release Date: 04/03/2020
Preventing Disease Through Diet with Dr. James O'Keefe
Evolving Past Alzheimer's
James O’Keefe is the director of preventative cardiology at St Louis Mid-America Heart Institute in Kansas City and a professor of medicine at the University of Missouri. Dr O’Keefe taught me that checking your blood sugar right after you eat is really important. And even healthy people may see a huge spike in their blood sugar right after they eat. Many different chronic diseases are linked to problems with blood sugar.
info_outline
Methylene Blue & It’s Potential in Alzheimer’s
Evolving Past Alzheimer's
Part 2 of the conversation with Francisco Gonzalez-Lima. We are talking about Methylene Blue as a potential therapy for Alzheimer’s. This is something that you can access yourself with the proper research needed to obtain a pharmaceutical grade. We talk about its potential as a therapy for early intervention and prevention of Alzheimer’s.
info_outline
Brain Energetics & 2 New Potential Therapies in Alzheimer's
Evolving Past Alzheimer's
This is a super technical episode. The guest is a world leader in brain energy and its impact on cognition and cognitive change that leads to Alzheimer’s. We had to break this episode into two parts.
info_outline
The End of Alzheimer’s with Dr. Dale Bredesen
Evolving Past Alzheimer's
Dr. Dale Bredesen is a neuroscientist of the first order as well as a truly pioneering doctor in the fields of Alzheimer’s and Parkinson’s research.
info_outline
BrainSee - Early Detection of Alzheimer's
Evolving Past Alzheimer's
The field of preventive neurology is coming. Detection of early brain damage is critical and our guest this episode, Darmiyan appears to have developed this technology. A highly technical, but potentially game-changing episode.
info_outline
Cognitive Benefits of Crossfit...Yes even for "older" brains and bodies!
Evolving Past Alzheimer's
In Feb 2018 Michele Mootz started the CrossFit Wellness Program focused on bringing CrossFit to populations that were not being addressed including those with serious chronic diseases as well as aging adults over 65 including those with cognitive impairment. We discuss the tremendous benefits they have seen to date. We also discuss the impact COVID has had on this program and the overall health of this community of individuals.
info_outline
More on COVID-19 & the Brain
Evolving Past Alzheimer's
In this episode we talk with neurologist Suzanne Gazda MD. Dr Gazda is an authority on neurodegenerative diseases and offers more insight to balancing the "mental" vs "physical" risks in the age of coronavirus and social distancing. We focus on inflammation, auto-immune disease, Alzheimer's, and isolation.
info_outline
NeuroCOVID & Alzheimer's. What You Can Do To Protect Yourself
Evolving Past Alzheimer's
This is a review of the neurological symptoms that are associated with COVID-19. We discuss the implications of COVID-19 on Alzheimer's disease and other dementias. We discuss what you can do to protect yourself.
info_outline
Telomerase Therapy for Alzheimer's?
Evolving Past Alzheimer's
Dr Michael Fossel received his MD and his PhD from Stanford University. He has published numerous articles in both high impact medical journals and popular press. His book The Telomerase Revolution was hailed by the WSJ as one of the five best science books of 2015.
info_outline
Light Therapy for Alzheimer's - Part 2 transcranial photobiomodulation
Evolving Past Alzheimer's
This is the second part of a rich discussion between Anita Saltmarche and Dr Nate Bergman. It features transcranial photobiomodulation (PBM), or shining LED light energy into the brain. Anita has led numerous clinical trials and has over 17 years of experience with this technology. A good discussion about which devices, how much to use, and more information about the VieLight product
info_outlineThis is, Dr Nate Bergman on a solocast chatting about 3 cases of improvement with Alzheimer's and cognitive impairment. We are excited to be part of the changing conversation within the Alzheimer's and Dementia communities. Increasingly, the question isn't so much IF someone will improve, it's more of a question of how much.